Australia markets open in 7 hours 57 minutes

Cocrystal Pharma Inc (8CC.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.7400-0.0200 (-1.14%)
As of 04:03PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-16,751
-17,984
-38,837
-14,185
-9,648
Depreciation & amortisation
-1,402
-1,388
388
382
157
Stock-based compensation
667
801
855
724
662
Change in working capital
-135
2,342
-2,712
170
-878
Accounts receivable
-
-
0
556
88
Other working capital
-16,139
-14,784
-21,509
-12,771
-10,070
Other non-cash items
-
1,563
-209
239
-177
Net cash provided by operating activities
-16,058
-14,666
-21,435
-12,719
-9,830
Cash flows from investing activities
Investments in property, plant and equipment
-81
-118
-74
-52
-240
Net cash used for investing activities
-81
-118
-74
-52
-240
Cash flows from financing activities
Debt repayment
0
-7
-27
-39
-121
Common stock issued
-
4,000
0
38,505
35,783
Net cash used provided by (used for) financing activities
4,000
3,993
-27
38,466
35,662
Net change in cash
-12,139
-10,791
-21,536
25,695
25,592
Cash at beginning of period
34,056
37,219
58,755
33,060
7,468
Cash at end of period
21,917
26,428
37,219
58,755
33,060
Free cash flow
Operating cash flow
-16,058
-14,666
-21,435
-12,719
-9,830
Capital expenditure
-81
-118
-74
-52
-240
Free cash flow
-16,139
-14,784
-21,509
-12,771
-10,070